SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001015402-05-002600
Filing Date
2005-05-16
Accepted
2005-05-16 15:45:10
Documents
6
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 10QSB-1Q-2005 q1q2005.htm 10QSB 288837
2 CEO CERT - 302 certceo302.htm EX-31.1 11598
3 CFO CERT 302 cfocert302.htm EX-31.2 11751
4 CEO CERT 906 ceocert906.htm EX-32.1 5854
5 CFO CERT 906 cfocert906.htm EX-32.2 6224
6 RISK FACTORS riskfactors.htm EX-99.1 62296
  Complete submission text file 0001015402-05-002600.txt   388166
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 05834119
SIC: 2834 Pharmaceutical Preparations